MS

Mahesh Srivastava

Active Director Director DIN 06981100
DIN 06981100 First appointment Dec 2014 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2014
Shareholding value •••• Premium profile

About Mahesh Srivastava

Data last updated:

Mahesh Srivastava is a Director at Alexin Ophthalmics Private Limited (since 2014). The company operates in Healthcare. Alexin Ophthalmics Private Limited reported revenue of ₹57.4 Lakh (FY 2025).

DIN 06981100
Primary Designation Director
Industry Healthcare
First Appointment 24 Dec 2014
Oldest Company Age 11 yrs
Largest company Alexin Ophthalmics Private Limited · ₹57.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alexin Ophthalmics Private Limited U24233UP2014PTC067808
Director24 Dec 20142014₹57.4 Lakh (FY 2025)Active

Board colleagues of Mahesh Srivastava

NameDINCompanyDesignation
Ruby Srivastava06981110Alexin Ophthalmics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alexin Ophthalmics Private Limited
Premium access

Shareholding and investment profile for Mahesh Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Srivastava

Mahesh Srivastava currently holds 1 directorship: Alexin Ophthalmics Private Limited (Director, since 24 Dec 2014, revenue ₹57.4 Lakh (FY 2025)).

Mahesh Srivastava was first appointed on 24 Dec 2014 as Director at Alexin Ophthalmics Private Limited.

The current boards of Mahesh Srivastava's companies include Ruby Srivastava (Alexin Ophthalmics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available